Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$25.89 - $29.73 $82,692 - $94,957
3,194 New
3,194 $88,000
Q3 2023

Oct 12, 2023

SELL
$32.09 - $37.51 $16,590 - $19,392
-517 Reduced 6.57%
7,356 $243,000
Q2 2023

Jul 11, 2023

SELL
$36.12 - $41.79 $64,763 - $74,929
-1,793 Reduced 18.55%
7,873 $288,000
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $57,903 - $75,381
-1,470 Reduced 13.2%
9,666 $394,000
Q4 2022

Jan 18, 2023

BUY
$41.75 - $54.5 $123,287 - $160,938
2,953 Added 36.09%
11,136 $0
Q3 2022

Oct 28, 2022

BUY
$43.76 - $53.42 $8,927 - $10,897
204 Added 2.56%
8,183 $358,000
Q2 2022

Jul 26, 2022

BUY
$46.53 - $55.17 $93 - $110
2 Added 0.03%
7,979 $418,000
Q1 2022

Apr 18, 2022

SELL
$45.75 - $56.69 $2,058 - $2,551
-45 Reduced 0.56%
7,977 $413,000
Q4 2021

Jan 26, 2022

BUY
$41.32 - $61.25 $5,784 - $8,575
140 Added 1.78%
8,022 $474,000
Q3 2021

Oct 19, 2021

BUY
$39.25 - $50.42 $91,177 - $117,125
2,323 Added 41.79%
7,882 $339,000
Q4 2020

Jan 26, 2021

BUY
$33.47 - $42.56 $55,861 - $71,032
1,669 Added 42.9%
5,559 $205,000
Q3 2020

Oct 21, 2020

BUY
$31.75 - $37.25 $123,507 - $144,902
3,890 New
3,890 $143,000
Q4 2019

Jan 27, 2020

SELL
$32.92 - $37.36 $69,527 - $78,904
-2,112 Closed
0 $0
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $68,618 - $88,978
2,112 New
2,112 $76,000
Q4 2017

Feb 01, 2018

SELL
$33.26 - $35.29 $109,591 - $116,280
-3,295 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$31.0 - $34.15 $102,145 - $112,524
3,295
3,295 $118,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Northwest Investment Counselors, LLC Portfolio

Follow Northwest Investment Counselors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Investment Counselors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Investment Counselors, LLC with notifications on news.